These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 29341226)
21. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells. Hamill P; Jean F Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392 [TBL] [Abstract][Full Text] [Related]
22. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease. Morikawa K; Gouttenoire J; Hernandez C; Dao Thi VL; Tran HT; Lange CM; Dill MT; Heim MH; Donzé O; Penin F; Quadroni M; Moradpour D Hepatology; 2014 Feb; 59(2):423-33. PubMed ID: 23929719 [TBL] [Abstract][Full Text] [Related]
23. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus. Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724 [TBL] [Abstract][Full Text] [Related]
24. Multiscale simulations on conformational dynamics and membrane interactions of the non-structural 2 (NS2) transmembrane domain. Hung HM; Hang TD; Nguyen MT Biochem Biophys Res Commun; 2016 Sep; 478(1):193-198. PubMed ID: 27444387 [TBL] [Abstract][Full Text] [Related]
25. Interaction between the NS4B amphipathic helix, AH2, and charged lipid headgroups alters membrane morphology and AH2 oligomeric state--Implications for the Hepatitis C virus life cycle. Ashworth Briggs EL; Gomes RG; Elhussein M; Collier W; Findlow IS; Khalid S; McCormick CJ; Williamson PT Biochim Biophys Acta; 2015 Aug; 1848(8):1671-7. PubMed ID: 25944559 [TBL] [Abstract][Full Text] [Related]
26. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease. Fatima K; Tahir M; Qadri I Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947 [TBL] [Abstract][Full Text] [Related]
27. A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication. Benureau Y; Warter L; Malcolm BA; Martin A Virology; 2010 Oct; 406(2):228-40. PubMed ID: 20701941 [TBL] [Abstract][Full Text] [Related]
28. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Franco S; Clotet B; Martínez MA Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183 [TBL] [Abstract][Full Text] [Related]
29. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase. Liu D; Wang YS; Gesell JJ; Wyss DF J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566 [TBL] [Abstract][Full Text] [Related]
30. The nonstructural proteins of the hepatitis C virus: structure and functions. Neddermann P; Tomei L; Steinkühler C; Gallinari P; Tramontano A; De Francesco R Biol Chem; 1997 Jun; 378(6):469-76. PubMed ID: 9224925 [TBL] [Abstract][Full Text] [Related]
31. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile. Martin MM; Condotta SA; Fenn J; Olmstead AD; Jean F Biol Chem; 2011 Oct; 392(10):927-35. PubMed ID: 21749281 [TBL] [Abstract][Full Text] [Related]
32. Host APOBEC3G protein inhibits HCV replication through direct binding at NS3. Zhu YP; Peng ZG; Wu ZY; Li JR; Huang MH; Si SY; Jiang JD PLoS One; 2015; 10(3):e0121608. PubMed ID: 25811715 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation. Zhou Y; Zhao Y; Gao Y; Hu W; Qu Y; Lou N; Zhu Y; Zhang X; Yang H J Exp Clin Cancer Res; 2017 Mar; 36(1):42. PubMed ID: 28283039 [TBL] [Abstract][Full Text] [Related]
34. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation. Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771 [TBL] [Abstract][Full Text] [Related]
35. Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach. Ashfaq UA; Jalil A; Ul Qamar MT Nat Prod Res; 2016 Aug; 30(16):1866-9. PubMed ID: 26274064 [TBL] [Abstract][Full Text] [Related]
36. N-terminal AH2 segment of protein NS4B from hepatitis C virus. Binding to and interaction with model biomembranes. Palomares-Jerez MF; Nemesio H; Franquelim HG; Castanho MA; Villalaín J Biochim Biophys Acta; 2013 Aug; 1828(8):1938-52. PubMed ID: 23639583 [TBL] [Abstract][Full Text] [Related]
37. Single-cell resolution imaging of membrane-anchored hepatitis C virus NS3/4A protease activity. Martin MM; Jean F Biol Chem; 2006 Aug; 387(8):1075-80. PubMed ID: 16895477 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus NS3/4A protease. Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580 [TBL] [Abstract][Full Text] [Related]
39. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic. Tsantrizos YS Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268 [TBL] [Abstract][Full Text] [Related]
40. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease. Hiscott J; Lacoste J; Lin R Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]